Kira Pharma
莹 王 has worked in the finance industry since 2004. 莹 began their career at 安阳 as an Audit Senior. In 2009, they joined Synthesis Energy System Inc as Commercial & Finance Director and Financial Planning & Analysis Manager. In 2018, they moved to Eddingpharm as Director of Finance and, in 2020, they took on the role of Finance Director at Kira Pharmaceuticals.
莹 王 received their Master of Business Administration (MBA) from China Europe International Business School (CEIBS) between 2015 and 2017. 莹 also obtained their Bachelor's degree from Nankai University in 2004, where they studied International Economics and Trade.
This person is not in any teams
This person is not in any offices
Kira Pharma
Kira Pharmaceuticals is a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases. Enabled by its proprietary LOGIC drug discovery platform, Kira is committed to advancing first-in-class and best-in-class therapies to patients around the world. The company is headquartered in Cambridge, Massachusetts with an R&D center in Suzhou, China.